Why First Advantage (FA) Is Down 8.0% After Equity Raise And Higher 2026 Revenue Guidance – And What's Next

First Advantage Corp.

First Advantage Corp.

FA

0.00

  • In August 2026, First Advantage Corporation completed a US$277.5 million follow-on equity offering of 12,500,000 common shares at US$22.20 each, shortly after filing a US$2.10 billion common stock shelf registration and reporting stronger second-quarter 2026 results with higher sales and a return to profitability.
  • The company also raised its full-year 2026 revenue guidance to a range of US$1.67 billion to US$1.71 billion, signaling management’s increased confidence following large contract wins and progress on its FA 5.0 growth initiatives.
  • Now we’ll examine how the raised 2026 revenue guidance and recent capital-raising activities affect First Advantage’s existing investment narrative.

Capitalize on the AI infrastructure supercycle with our selection of the 55 best 'picks and shovels' of the AI gold rush converting record-breaking demand into massive cash flow.

First Advantage Investment Narrative Recap

To own First Advantage, you need to believe its background screening and identity platform can keep winning large, recurring enterprise contracts even if hiring slows. The raised 2026 revenue guidance and return to profitability support that thesis in the near term, while the biggest risk remains pressure on hiring volumes and pricing in a crowded market. The new equity raise modestly softens the impact of the buyback and adds dilution, but it does not fundamentally change that core risk-reward balance.

Among the recent announcements, the higher 2026 revenue guidance to US$1.67 billion to US$1.71 billion feels most directly connected to the follow on equity raise. Guidance now reflects recent contract wins and traction in FA 5.0 initiatives, which many investors see as the key short term catalyst for the stock. How effectively those initiatives offset competitive pressure and customer concentration risk will be crucial as the year unfolds.

Yet even with stronger guidance and fresh capital, investors should still pay close attention to how concentrated exposure to large enterprise customers could...

First Advantage's narrative projects $1.9 billion revenue and $210.5 million earnings by 2029. This requires 6.6% yearly revenue growth and about a $202 million earnings increase from $8.5 million today.

Uncover how First Advantage's forecasts yield a $18.86 fair value, a 15% downside to its current price.

Exploring Other Perspectives

FA 1-Year Stock Price Chart
FA 1-Year Stock Price Chart

Some of the most optimistic analysts were already assuming revenues near US$2.0 billion and earnings of about US$287.6 million by 2029, so if you see compliance driven, cross border screening demand as their main catalyst, this new guidance and capital raise might either reinforce that view or prompt you to question how realistic those expectations really are.

Explore 2 other fair value estimates on First Advantage - why the stock might be worth over 2x more than the current price!

Decide For Yourself

Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.

  • A great starting point for your First Advantage research is our analysis highlighting 3 key rewards and 1 important warning sign that could impact your investment decision.
  • Our free First Advantage research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate First Advantage's overall financial health at a glance.

Want Some Alternatives?

Our daily scans reveal stocks with breakout potential. Don't miss this chance:

  • Uncover the next big thing with 20 elite penny stocks that balance risk and reward.
  • The best AI stocks today may lie beyond giants like Nvidia and Microsoft. Find the next big opportunity with these 17 smaller AI-focused companies with strong growth potential through early-stage innovation in machine learning, automation, and data intelligence that could fund your retirement.
  • AI is about to change healthcare. These 44 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.